BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9637257)

  • 1. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.
    Wörn A; Plückthun A
    FEBS Lett; 1998 May; 427(3):357-61. PubMed ID: 9637257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K; Honegger A; Plückthun A
    J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
    Ramm K; Gehrig P; Plückthun A
    J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
    Wörn A; Plückthun A
    Biochemistry; 1999 Jul; 38(27):8739-50. PubMed ID: 10393549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
    J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
    ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
    Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
    Jäger M; Plückthun A
    J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions.
    Reiter Y; Brinkmann U; Kreitman RJ; Jung SH; Lee B; Pastan I
    Biochemistry; 1994 May; 33(18):5451-9. PubMed ID: 7910034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual cysteine V
    Attallah C; Aguilar MF; Garay AS; Herrera FE; Etcheverrigaray M; Oggero M; Rodrigues DE
    Mol Immunol; 2017 Oct; 90():143-149. PubMed ID: 28755586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
    Nieba L; Honegger A; Krebber C; Plückthun A
    Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
    Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
    Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
    Jäger M; Plückthun A
    FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
    Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
    Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm.
    Martineau P; Betton JM
    J Mol Biol; 1999 Oct; 292(4):921-9. PubMed ID: 10525415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-chain anti-DNA FV.
    Polymenis M; Stollar BD
    Methods Mol Biol; 1995; 51():265-79. PubMed ID: 7581703
    [No Abstract]   [Full Text] [Related]  

  • 19. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli.
    Glockshuber R; Schmidt T; Plückthun A
    Biochemistry; 1992 Feb; 31(5):1270-9. PubMed ID: 1736986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M; Gehrig P; Plückthun A
    J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.